alexa Metabolic Vulnerabilities In Cancer Stem Cells
ISSN: 2153-0769

Metabolomics:Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

8th International Conference and Exhibition on Metabolomics & Systems Biology
May 08-10, 2017 Singapore

Wai Leong TAM
Principal Investigator
Genome Institute of Singapore, A*STAR and Cancer Science Institute of Singapore, National University of Singapore, Singapore
ScientificTracks Abstracts: Metabolomics
DOI: 10.4172/2153-0769-C1-037
Tumors are highly heterogeneous. One of the grand challenges for cancer treatment is that current therapeutic strategies to treat tumors are ineffective due to therapy resistance and tumor recurrence that are caused by cancer stem cells (CSCs). We address this important challenge by integrating the fields of cancer, CSC, targeted therapy, and disease modeling, to translate biological findings about CSCs into innovative, targeted cancer therapies. Advanced multidisciplinary approaches are employed to uncover and interrogate emerging paradigms in CSC biology that include their metabolic dependencies, differentiation capabilities and heterogeneous nature. This will reveal facets of CSCs that are amendable to rationally designed targeted therapies. In the long-term, the development of these agents will provide novel therapeutic modalities which can be employed as neoadjuvants for cancer treatment.

Wai Leong TAM received his Bachelor’s degree from the NUS in 2003. He performed his graduate studies in the laboratory of Bing Lim at the Genome Institute of Singapore, where he worked on uncovering the bases for the pluripotency of embryonic stem cells and induced pluripotent stem cells. In 2009, Wai Leong began his postdoctoral training under the mentorship of Robert Weinberg at the Whitehead Institute in MIT, where he concentrated on understanding breast cancer stem cell biology and cancer metastasis. He joined the Genome Institute of Singapore (A*STAR) and the Cancer Science Institute of Singapore (NUS) as a Principal Investigator in 2014. He is an adjunct faculty member at the Yong Loo Lin School of Medicine, NUS. His lab currently focuses on uncovering and interrogating the emerging paradigms of cancer stem cells, and designing rational strategies to specifically target cancer stem cells as a part of cancer therapy.

Email: [email protected]

image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version